Showing results (71-80 of 375) with videos related to
Sort By:
Pageof 38
World Journal of Nuclear Medicine|June 21, 2023
Assessment of Pulmonary Metastasis in Differentiated Thyroid Carcinoma: Value of HRCT Correlation with Functional ImagingAshwini Kalshetty, Sandip BasuIndian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|November 3, 2018
Solitary Metacarpophalangeal Metastasis from Poorly Differentiated Thyroid Carcinoma: Excellent Tumor Marker and Scan Response to Two Fractions of Radioiodine TherapySonam Suman, Sandip BasuJournal of Nuclear Medicine Technology|December 7, 2021
Differential tumor biology between locoregional and distant metastasis in a patient with TENIS with TKI-resistant aggressive recurrent disease: a comparative evaluation with FDG, 68Ga-DOTATATE and 68Ga-PSMA-11 PET-CTSunita Nitin Sonavane, Sandip BasuNuclear Medicine Communications|May 2, 2015
Relevance of a thyroid phantom in estimating thyroid radioiodine uptake values using a gamma cameraBiju K Menon, Sandip BasuClinical Nuclear Medicine|April 1, 2024
Cutaneous, Subcutaneous, and Bilateral Adrenal Gland Metastases in Progressive Prostate Carcinoma: Theranostic Potential of 68 Ga-PSMA-11 PET/CT Imaging and 177 Lu-PSMA-617 TherapyRahul V Parghane, Sandip BasuWorld Journal of Nuclear Medicine|March 16, 2023
"Stocking Pattern Metabolic Captivity" of Legs on 18 F-FDG PET-CT in Necrotizing Fasciitis: Potential Complimentary Role in Differential Diagnosis and Assessment of Disease Extent in a Life-Threatening ConditionSunita Nitin Sonavane, Sandip BasuWorld Journal of Nuclear Medicine|April 10, 2024
Unusual Metastatic Sites of Testis and Rectum in Prostate Cancer Detected by 68 Ga-PSMA-11 PET/CT Imaging at Initial StagingRahul V Parghane, Sandip BasuPET Clinics|November 19, 2019
PET/Computed Tomography in Treatment Response Assessment in Cancer: An Overview with Emphasis on the Evolving Role in Response Evaluation to Immunotherapy and Radiation TherapyRahul V Parghane, Sandip BasuSeminars in Nuclear Medicine|June 7, 2017
Dual-time point 18F-FDG-PET and PET/CT for Differentiating Benign From Malignant Musculoskeletal Lesions: Opportunities and LimitationsRahul V Parghane, Sandip BasuClinical Nuclear Medicine|March 30, 2022
177 Lu-DOTATATE PRRT for Multiple Unusual Metastatic Sites in Neuroendocrine TumorRahul V Parghane, Sandip BasuPageof 38